Loading…
5 companies · GEL, thousands · columns ordered by revenue
| Company | Sector | EBITDA margin · FY 2024 | Percentile | Sector n |
|---|---|---|---|---|
| CIS Pharma | Pharma | 51.7% | 97th pct | 110 |
| Welfare International | Pharma | 31.6% | 75th pct | 110 |
| Gea | Pharma | 8.0% | 35th pct | 110 |
| Ivermedi | Pharma | -2.4% | 11th pct | 110 |
| Mermisi | Pharma | — | no FY data | 110 |
Percentile is within each company's own sector across the whole FY2024 cross-section (1st–100th; higher = larger value). Companies with no sector, or no filing for the year, are not ranked.
Only 4 of 5 peers filed FY2024. Switch to FY2023 (5 of 5).
| Line item | CIS Pharma | Gea | Ivermedi | Welfare International | Mermisi |
|---|---|---|---|---|---|
| Total Current Assets | 50,145 | 36,571 | 23,327 | 24,687 | — |
| Total Non-Current Assets | 2,678 | 13,485 | 15,587 | 6 | — |
| TOTAL ASSETS | 52,823 | 50,056 | 38,914 | 24,693 | — |
| Total Current Liabilities | 20,066 | 7,897 | 7,571 | 15,803 | — |
| Total Non-Current Liabilities | 0 | 4,354 | 500 | 0 | — |
| TOTAL LIABILITIES | 20,066 | 12,251 | 8,071 | 15,803 | — |
| Total Equity | 32,757 | 37,806 | 30,843 | 8,890 | — |
| Balance Check (Assets - L&E) | 0 | 0 | 0 | 0 | — |
| Total Debt | 424 | 5,228 | 598 | 0 | — |
| Cash & Equivalents | 29 | 1,470 | 9,676 | 5 | — |
| Net Debt | 394 | 3,758 | -9,078 | -5 | — |
Not every picked company reports every selected year — FY2024: no filing for Mermisi. Those cells are left blank (no filing), not zero.